2m 2m 2m 2m 2m 2m 2m
DAMORA THERAP (DMRA)
NASDAQ
$21.68-$0.04 (-0.16%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.9BMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
DAMORA THERAP (DMRA)
$21.68-$0.04 (-0.16%)
DMRA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.71 | ||
Change | +$0.86 (+4.16%) | ||
Open | $21.45 | ||
High | $21.88 | ||
Low | $20.92 | ||
Previous Close | $21.53 | ||
Volume | 420,641 | ||
30-Day Average Volume | 566,038 | ||
1-Week Change | 16.82% | ||
1-Month Change | -5.78% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 61.7M | ||
Total Assets | $543.6M | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $4.1M | ||
Net Income | -$31.2M | ||
Free Cash Flow | -$21.9M | ||
EBIT | -$30.9M | ||
EBITDA | -$30.9M | ||
Net Working Capital | $516.0M | ||
EPS | -$393.59 | ||
Enterprise Value/EBITDA | -45 | ||
Enterprise Value/Revenue | 344 | ||
P/B | 3 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -61 | ||
Price/Operating Cash Flow | -61 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue